Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Call for papers: strengthening primary care through integrated clinical pharmacy services-models, outcomes and implementation.

International journal of clinical pharmacy·2026
Same author

Identification and distribution of a downregulatory signaling alkyloxazole in <i><i>Streptomyces</i></i>.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

The Management of Acne in General Practice using Isotretinoin: A Scoping Review Protocol.

HRB open research·2026
Same author

Maternal socioeconomic status and neonatal mortality in OECD countries: a systematic review and meta-analysis protocol.

BMJ open·2026
Same author

Patient needs and preferences for a kidney stone self-monitoring app: a pilot survey analysis.

Urolithiasis·2026
Same author

HIV and HCV Screening, and Pre-Exposure Prophylaxis Among Managed Care Beneficiaries with Substance Use Disorders: A Cross-Sectional Study from a Single State.

Risk management and healthcare policy·2025

Related Experiment Video

Updated: Jun 3, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

Does satisfaction with information equate to better anticoagulant control?

Laura Sahm1, Lisa Quinn, Michael Madden

  • 1School of Pharmacy, University College Cork, College Road, Cork, Republic of Ireland. L.Sahm@ucc.ie

International Journal of Clinical Pharmacy
|March 29, 2011
PubMed
Summary

Patient satisfaction with warfarin information varied by age. Understanding the medicine's purpose was linked to better anticoagulation control, improving warfarin therapy outcomes.

Related Experiment Videos

Last Updated: Jun 3, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

Area of Science:

  • Pharmacology and Therapeutics
  • Patient Education and Adherence

Background:

  • Warfarin is a critical anticoagulant medication requiring careful patient management.
  • Patient understanding of medication is crucial for therapeutic success and adherence.
  • Assessing patient satisfaction with medical information is vital for optimizing healthcare delivery.

Purpose of the Study:

  • To investigate the relationship between patient satisfaction with warfarin information and demographic/clinical factors.
  • To explore the association between satisfaction with information and therapeutic outcomes, specifically anticoagulation control (INR).

Main Methods:

  • A cross-sectional study was conducted at an anticoagulation clinic in Ireland.
  • 119 patients on warfarin completed the Satisfaction with Information about Medicines (SIMS) Scale.
  • Data collected included demographics, diagnosis, duration of warfarin use, and INR control.

Main Results:

  • Higher satisfaction with warfarin information was inversely correlated with patient age (ρ = -0.33, P < 0.01).
  • Patient understanding of 'what is your medicine for?' was significantly associated with better anticoagulation control (χ(2) = 7.27, P < 0.01).
  • Atrial fibrillation was the most common indication for warfarin therapy (53.8%).

Conclusions:

  • Patient satisfaction with warfarin information is influenced by age.
  • Clear communication regarding the purpose of warfarin is directly linked to improved therapeutic outcomes.
  • Targeted patient education strategies may enhance warfarin management and patient safety.